Apo E gene polymorphism on development of diabetic nephropathy
| dc.contributor.author | Ilhan, Necip | |
| dc.contributor.author | Kahraman, Neslihan | |
| dc.contributor.author | Seckin, Dilara | |
| dc.contributor.author | Ilhan, Nevin | |
| dc.contributor.author | Colak, Ramis | |
| dc.date.accessioned | 2026-08-12T17:13:39Z | |
| dc.date.issued | 2007 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Type 2 diabetes causes premature morbidity and mortality due to the complications of atherosclerosis and diabetic nephropathy (DN). Polymorphism of Apo E gene is known to influence lipid metabolism. Apo E is polymorphic, consisting of three common isoforms (epsilon 2, epsilon 3 and epsilon 4) encoded by three alleles (2, 3 and 4) in exon 4 on chromosome 19. The aim of this study was to investigate the effect of Apo E polymorphism as a prognostic risk factor for the development of DN. A total of 108 NIDDM patients were recruited from the Nephrology and Endocrinology Departments of our hospital. All subjects were divided into three groups: Group I: diabetes with nephropathy (n:37), group II: diabetes without nephropathy (n:71), group III: controls (n:46). Apo E genotypes were determined by real-time PCR. The epsilon 4 allele frequency was significantly higher in-group I (10.8%) than in-group III (2.2%), (p < 0.05). In diabetics without nephropathy, the total cholesterol and LDL cholesterol levels were significantly lower in subjects with epsilon 2 alleles than epsilon 3 and epsilon 4 alleles. In conclusion, the present prospective study indicates that the epsilon 4 allele of the Apo E polymorphism is one of the prognostic risk factors involved in the development of DN with type 2 diabetes mellitus. Copyright (c) 2006 John Wiley & Sons, Ltd. | |
| dc.identifier.doi | 10.1002/cbf.1348 | |
| dc.identifier.endpage | 532 | |
| dc.identifier.issn | 0263-6484 | |
| dc.identifier.issn | 1099-0844 | |
| dc.identifier.issue | 5 | |
| dc.identifier.orcid | 0000-0002-0208-8929 | |
| dc.identifier.orcid | 0000-0001-9997-0418 | |
| dc.identifier.orcid | 0000-0002-0208-8929 | |
| dc.identifier.pmid | 16933203 | |
| dc.identifier.scopus | 2-s2.0-34548768175 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 527 | |
| dc.identifier.uri | https://doi.org/10.1002/cbf.1348 | |
| dc.identifier.uri | https://hdl.handle.net/11508/51518 | |
| dc.identifier.volume | 25 | |
| dc.identifier.wos | WOS:000249634900009 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Wiley | |
| dc.relation.ispartof | Cell Biochemistry and Function | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | diabetic nephropathy | |
| dc.subject | Apo E gene polymorphism | |
| dc.title | Apo E gene polymorphism on development of diabetic nephropathy | |
| dc.type | Article |







